Mid-regional pro-atrial natriuretic peptide to predict clinical course in heart failure patients undergoing cardiac resynchronization therapy-Reference-Cited by-同舟云学术

Mid-regional pro-atrial natriuretic peptide to predict clinical course in heart failure patients undergoing cardiac resynchronization therapy

Published:2017-01-17 Issue:11 Volume:19 Page:1848-1854
ISSN:1099-5129
Container-title:EP Europace
language:en
Short-container-title:

Author:

Arrigo Mattia¹²³⁴,Truong Quynh A.⁵,Szymonifka Jackie⁵,Rivas-Lasarte Mercedes¹,Tolppanen Heli¹,Sadoune Malha¹,Gayat Etienne¹²,Cohen-Solal Alain¹³,Ruschitzka Frank⁴,Januzzi James L⁶,Singh Jagmeet P⁶,Mebazaa Alexandre¹²⁷

Affiliation:

1. INSERM UMR-S 942, Paris, France

2. Department of Anesthesiology and Critical Care Medicine, APHP, Saint Louis and Lariboisière University Hospitals, 2, rue Ambroise Paré, Paris 75010, France

3. Department of Cardiology, APHP, Lariboisière University Hospitals, Paris, France

4. Division of Cardiology, University Heart Center, University Hospital Zurich, Zurich, Switzerland

5. Dalio Institute of Cardiovascular Imaging, New York-Presbyterian Hospital and Weill Cornell Medical College, New York, NY, USA

6. Division of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

7. Université Paris Diderot, PRES Sorbonne Paris Cité, Paris, France

Funder

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/europace/article-pdf/19/11/1848/24119759/euw305.pdf

Reference20 articles.

1. The effect of cardiac resynchronization on morbidity and mortality in heart failure;Cleland;N Engl J Med,2005

2. Cardiac-resynchronization therapy for mild-to-moderate heart failure;Tang;N Engl J Med,2010

3. Cardiac-resynchronization therapy in heart failure with a narrow QRS complex;Ruschitzka;N Engl J Med,2013

4. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA);Brignole;Europace,2013

5. Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up;Ypenburg;J Am Coll Cardiol,2009

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natriuretic peptides as biomarkers and therapeutic target in heart failure;Journal of Cancer Prevention & Current Research;2024

2. Updated insights into predictive biomarkers for response to cardiac resynchronization therapy - A literature review;Revista Romana de Medicina de Laborator;2023-10-01

3. Multi-biological functions of intermedin in diseases;Frontiers in Physiology;2023-09-06

4. Combination Biomarkers for Risk Stratification in Patients With Chronic Heart Failure Biomarkers Prognostication in HF;Journal of Cardiac Failure;2021-12

5. Cyclic GMP modulating drugs in cardiovascular diseases: mechanism-based network pharmacology;Cardiovascular Research;2021-07-16